Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.
Donald E StullC E M GriffithsI GilloteauY ZhaoA GuanaA Y FinlayB SherifK HoughtonLluis L PuigPublished in: The British journal of dermatology (2018)
The results underscore the important role of both PASI response and reduction in symptoms on improvements in health-related quality of life and work and daily activity in favour of secukinumab vs. ustekinumab.